Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 24.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4222
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 24.  Àüü±Û: 211  ¹æ¹®¼ö: 1023659
150 Á¦49Â÷ ´ëÇÑÈäºÎ½ÉÀåÇ÷°ü¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2017.11.13.3430
149 Á¦20Â÷ Update symposium in pediatric cardiac surgery °ü¸®ÀÚ2017.08.14.3547
148 Á¦13Â÷ ÇÑÁßÀÏ ¼Ò¾Æ½ÉÀåÆ÷·³ °ü¸®ÀÚ2017.07.11.3224
147 2017 APCIS ( ¼¼Á¾º´¿øÁÖ°ü) °ü¸®ÀÚ2017.05.29.3587
146 25th Annual Meeting of ASCVTS °ü¸®ÀÚ2017.04.03.3459
145 Á¦17ȸ ´ëÇѼҾƽÉÀåÇÐȸÇмú´ëȸ °ü¸®ÀÚ2017.04.03.4364
144 Áß±¹½Éõ ¼ÕÀϼ±º´¿ø¹æ¹® °ü¸®ÀÚ2016.12.15.5418
143 Áß±¹ ÇϾóºó Áø·áÁö¿ø ¹× °­¿¬ °ü¸®ÀÚ2016.11.28.4305
142  ÀϺ» Sano ±³¼ö Á¤³â°­¿¬ °ü¸®ÀÚ2016.11.04.4127
141 ¼¼Á¾ÀÇÇבּ¸¼Ò ¼ÒÀåÃëÀÓ °ü¸®ÀÚ2016.09.04.4098
RELOAD WRITE
[1] [2] [3] 4 [5] [6] [7] [8] [9] [10]  ¢º 22